Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Viscido

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trialR Caprilli, M Cottone, F Tonelli, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
International Journal of Colorectal Disease|April 20, 2023
The connection between diverticulosis and colonic superficial neoplastic lesions in patients who underwent screening colonoscopyM Valvano, V Vezzaro, S Fabiani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2005
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statementR Caprilli, E Angelucci, A Cocco, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upA Kohn, M Daperno, A Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2005
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD studyG Riegler, L Caserta, F Castiglione, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2024
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational studyAlessandra Oliva, L Liguori, S Covino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 12, 2005
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open studyA Orlando, E Colombo, A Kohn, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trialR Caprilli, M Cottone, F Tonelli, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
International Journal of Colorectal Disease|April 20, 2023
The connection between diverticulosis and colonic superficial neoplastic lesions in patients who underwent screening colonoscopyM Valvano, V Vezzaro, S Fabiani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2005
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statementR Caprilli, E Angelucci, A Cocco, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upA Kohn, M Daperno, A Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2005
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD studyG Riegler, L Caserta, F Castiglione, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2024
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational studyAlessandra Oliva, L Liguori, S Covino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 12, 2005
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open studyA Orlando, E Colombo, A Kohn, et al.
Pageof 4